H Nakayama Selected Research

Fluorouracil (Carac)

10/2011	Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma.
7/2009	Pharmacokinetics of 5-fluorouracil in elderly Japanese patients with cancer treated with S-1 (a combination of tegafur and dihydropyrimidine dehydrogenase inhibitor 5-chloro-2,4-dihydroxypyridine).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Nakayama Research Topics

Disease

27	Neoplasms (Cancer) 01/2016 - 01/2000
9	Stroke (Strokes) 03/2004 - 01/2000
8	Infections 11/2016 - 01/2000
5	Adenocarcinoma 01/2016 - 03/2000
5	Carcinoma (Carcinomatosis) 07/2005 - 09/2000
4	Amyloid Plaque 02/2018 - 10/2001
4	Adenoma (Adenomas) 01/2016 - 03/2000
4	Neurologic Manifestations (Neurological Manifestations) 11/2015 - 01/2000
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2009 - 08/2000
4	Fibrosis (Cirrhosis) 01/2008 - 04/2000
4	Colorectal Neoplasms (Colorectal Cancer) 03/2004 - 01/2000
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 09/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 05/2000
3	Rheumatoid Arthritis 05/2015 - 08/2006
3	Necrosis 04/2013 - 04/2001
3	Lymphatic Metastasis 08/2008 - 09/2000
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2006 - 12/2001
3	Carcinogenesis 01/2006 - 01/2000
3	Lung Neoplasms (Lung Cancer) 10/2003 - 05/2000
2	Stomach Neoplasms (Stomach Cancer) 11/2019 - 01/2006
2	Osteoarthritis 04/2019 - 01/2017
2	Lymphoma (Lymphomas) 01/2018 - 01/2007
2	Hypertension (High Blood Pressure) 11/2016 - 09/2001
2	Mouth Neoplasms (Oral Cancer) 11/2016 - 09/2005
2	Hypersensitivity (Allergy) 06/2016 - 02/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2014 - 12/2013
2	Margins of Excision 05/2012 - 01/2001
2	Alzheimer Disease (Alzheimer's Disease) 04/2012 - 07/2008
2	Body Weight (Weight, Body) 04/2012 - 02/2001
2	Multiple System Atrophy 05/2011 - 03/2008
2	Parkinson Disease (Parkinson's Disease) 04/2006 - 12/2001
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2005 - 09/2000
2	Aberrant Crypt Foci 12/2004 - 02/2001
2	Hemorrhage 10/2003 - 01/2000
2	Pregnancy Complications 06/2003 - 08/2001
2	Diabetes Complications 12/2001 - 02/2001
2	Chagas Disease (American Trypanosomiasis) 11/2001 - 01/2000
2	Arteritis 04/2001 - 12/2000
2	Uterine Cervical Dysplasia 09/2000 - 01/2000
1	Osteogenesis Imperfecta (Lobstein Disease) 11/2019
1	Celiac Disease (Celiac Sprue) 01/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2018
1	Enteritis 01/2018
1	Diabetes Mellitus 11/2016

Drug/Important Bio-Agent (IBA)

4	AutoantibodiesIBA 11/2014 - 04/2000
4	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2006 - 09/2000
4	EnzymesIBA 02/2003 - 01/2000
4	DNA (Deoxyribonucleic Acid)IBA 11/2001 - 05/2001
3	Peptides (Polypeptides)IBA 01/2018 - 07/2001
3	Proteins (Proteins, Gene)FDA Link 11/2015 - 04/2006
3	Messenger RNA (mRNA)IBA 11/2013 - 03/2000
3	CytokinesIBA 11/2013 - 07/2000
3	Oxygen (Dioxygen)IBA 02/2011 - 01/2003
3	Phosphotransferases (Kinase)IBA 07/2010 - 12/2001
3	Protein Isoforms (Isoforms)IBA 02/2006 - 08/2000
3	Capsules (Microcapsules)IBA 07/2004 - 12/2002
2	AntibodiesIBA 01/2018 - 02/2003
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 05/2015
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 04/2012 - 01/2001
2	Fluorouracil (Carac)FDA LinkGeneric 10/2011 - 07/2009
2	Topoisomerase II InhibitorsIBA 01/2010 - 01/2006
2	Etoposide (VP 16)FDA LinkGeneric 01/2010 - 01/2006
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 03/2009 - 01/2009
2	Immunoglobulin E (IgE)IBA 11/2007 - 09/2000
2	Methotrexate (Mexate)FDA LinkGeneric 01/2007 - 08/2006
2	squamous cell carcinoma-related antigenIBA 05/2006 - 07/2005
2	Interleukin-18 (Interleukin 18)IBA 02/2006 - 08/2001
2	MucinsIBA 01/2006 - 01/2000
2	AzoxymethaneIBA 12/2004 - 02/2001
2	Calmodulin-Binding Proteins (Caldesmon)IBA 07/2004 - 12/2002
2	Monoclonal AntibodiesIBA 07/2004 - 05/2002
2	Blood Glucose (Blood Sugar)IBA 07/2002 - 01/2001
2	Advanced Glycation End ProductsIBA 12/2001 - 02/2001
2	benzonidazole (benznidazole)IBA 11/2001 - 01/2000
2	Mitochondrial DNA (mtDNA)IBA 11/2001 - 05/2001
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2001 - 06/2001
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2000 - 05/2000
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2000 - 03/2000
1	Collagen Type I (Type I Collagen)IBA 11/2019
1	alpha2 Subunit Collagen Type IIBA 11/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	AmelogeninIBA 02/2018
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2018
1	GliadinIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017
1	amyloid enhancing factorIBA 01/2017
1	Serum AlbuminIBA 11/2016

Therapy/Procedure

8	Radiotherapy 11/2016 - 11/2001
6	Therapeutics 03/2009 - 07/2002
5	Drug Therapy (Chemotherapy) 06/2016 - 05/2000
3	Home Nursing (Nursing, Home) 03/2004 - 06/2000
2	Osteotomy 04/2019 - 01/2017
2	Tracheostomy 10/2008 - 03/2008
2	Thoracotomy 10/2003 - 01/2000
2	Hysterectomy 01/2001 - 01/2000
1	Gastrectomy 11/2019